Navigation Links
OmniComm Ranks Number 220 on Deloitte's 2010 Technology Fast 500 for Fastest Growing Companies in North America
Date:10/22/2010

FORT LAUDERDALE, Fla., Oct. 22 /PRNewswire/ -- OmniComm Systems, Inc (OTC: OMCM.OB) today announced that it ranked number 220 on Technology Fast 500, Deloitte LLP's ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on the percentage of fiscal year revenue growth during the period from 2005-2009. OmniComm grew 445 percent during this period.

OmniComm's CEO, Cornelis F. Wit, credits the expansion of its customer base in the US and Europe and the addition of its new product lines with the company's 445% revenue growth. "We are very pleased to be ranked on the Technology Fast 500 list for the third time in the last 5 years," said Mr. Wit.  "Our growth has been steady with our existing EDC product line and the addition of our new eClinical product lines- including TrialOne for phase I automation and CDMS, CTMS, and Safety solutions have allowed us to enter into new markets."

"OmniComm and the other 2010 Technology Fast 500 winners forged ahead in a challenging economic environment to realize exceptional growth," said Phil Asmundson, vice chairman and Deloitte's U.S. technology, media and telecommunications leader. "Deloitte commends OmniComm for this impressive accomplishment."

"OmniComm has proved itself to be one of the fastest growing tech companies in North America, and we are proud to honor them as one of the 2010 Technology Fast 500," said Mark Jensen, managing partner, venture capital services, Deloitte & Touche LLP.

OmniComm previously ranked #284 as a Technology Fast 500 award winner in 2009, and earlier in 2005 as #140. Overall, Technology Fast 500 award winners for 2010 had revenue growth ranging from 146 percent to 164,709 percent from 2005 to 2009, with an average growth of 2,361 percent.

For additional detail on the Technology Fast 500 including selection and qualifying criteria, visit www.fast500.com

About OmniComm

OmniComm Systems, Inc (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver specific products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc has a U.S. Headquarters in Fort Lauderdale, FL. and European headquarters in Bonn, Germany, with satellite offices in New Jersey, and the United Kingdom. There are sales offices throughout the U.S. and Europe.

About Deloitte

As used in this document, "Deloitte" means Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.

Safe Harbor Disclaimer

Safe Harbor Disclaimer Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertainty regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand.  As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

CONTACT: Stephen Johnson at + 1 954-377-1726


'/>"/>
SOURCE OmniComm Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
2. OmniComm Systems, Inc. Experiences Record Year End Results - $18 Million in Signed Contracts for the Year 2008
3. OmniComm Systems Announces Settlement of Patent Litigation With DataSci, LLC
4. OmniComm Systems Announces 1st Quarter Results of Operations
5. OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific
6. OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology
7. Growing Midwestern Clinical Research Organization Selects OmniComm Systems to Provide eClinical Solutions for Phase IV Studies
8. OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.
9. Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study
10. OmniComm Systems Inc. Expands Its Successful CRO Preferred Program(TM) By Signing On Three New CRO Partners
11. MicroTech Ranks No. 285 on Inc. Magazines 2008 List of the 500 Fastest Growing Private Companies in America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... 2016 , ... PharmApprove announced today the hiring ... for Rare Disorders (NORD). Dorman will lead PharmApprove efforts to work with patients, ... drug regulatory review process. , “Adding Diane Dorman is just the latest in ...
(Date:2/9/2016)... Three-Year Initiative Supports Next Generation of Medical Geneticists and  ... Experiences SHPG ) ... of children born with rare diseases, as well as the future ... a new initiative designed to positively affect the lives of children ... disease care. --> To mark the company,s founding 30 ...
(Date:2/8/2016)... 8, 2016 Should antibiotic bone cement products ... to prevent infection after standard total hip or knee ... ECRI Institute have been fielding a lot lately. ... Bottom Line?" --> "Antibiotic Bone ... --> While there isn,t a simple ...
(Date:2/8/2016)... ... February 08, 2016 , ... Thomas J. Todorow has joined ... President for Corporate Services and the Chief Financial Officer at The Children’s Hospital ... Treasury, Managed Care Contracting, Supply Chain, and Investments. , Prior to joining CHOP ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce the ... achievements are the result of the company,s laser focus ... eClinical , it,s comprehensive, easy-to-use and highly affordable ... --> Key MedNet growth achievements in 2015 include: ...
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., ... that simplifies the use and access of ubiquitous ... go-to-market partnership with American Cyber.  ... extensive experience leading transformational C4ISR and Cyber initiatives ... integrating the latest proven technology solutions," said ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
Breaking Biology News(10 mins):